21 / 51
Page 77
Journal of Clinical Immunology and Allergy
ISSN: 2471-304X
E u r o p e a n C o n g r e s s o n
Vaccines & Vaccination
and Gynecologic Oncology
Vaccines & Vaccination and Gynecologic Oncology 2018
O c t o b e r 2 6 - 2 7 , 2 0 1 8
B u d a p e s t , H u n g a r y
T
he world’s most widespread epidemic of Ebola Virus Disease (EVD) began around December 2013. Within six months, cases were
found throughout Guinea, Liberia and Sierra Leone, countries that eventually suffered 28,616 cases and 11,310 deaths due to the
outbreak. Initial response was marked by disease surveillance gaps and weaknesses but heroic efforts eventually led to monumental
successes. Laboratory infrastructure in these countries was weak and unprepared to respond effectively. In Guinea, Santé plus Orga-
nization, the Ministry of health /National Laboratory Direction, with the support of CRDF GLOBAL and EMPHNET organized seven (7)
training of 120 peripheral laboratory agents in Bio risk (biosecurity and biosafety). The mains objective was to contribute to Guinea
laboratories’ system straightening on bio threat and bio risk reduction thought increase capacity building of laboratory agents in bi-
osecurity and biosafety. At the end, 120 participants have accomplished (certification) their training with an average of participants’
knowledge increased up to 80%. During the training sessions, some lessons were learnt including: the Full implication of administrative
and health authorities the great interest and satisfaction of participants to the topics covered. After 12 months following the regional
training sessions on bio risk training sessions, a Qualitative survey involving 110 out of 120 professional who completed the training
sessions organized: 110 /120 are in place working in their laboratory among with 90% declare sing their skills after training to improve
their biosecurity procedure especially the west management and the biomedical sample management (collect, conditioning and trans-
fer); More than half (60/110) interviewee declare “training their colleague on the use of the EPE”; Almost all of interviewee (90100/110)
declare “having organized sensitization sessions either with stakeholder or with the Community to address the bio threat risk preven-
tion especially in with Ebola Forecaria and Gueckedou place where Ebola have killed the most. Many of interviewee (80/110) declare
“improving the west management quality in their lab”; (40/110) interviewee declare “the need of a National bio risk policy in Guinea”.
Many of the trainees (100/110) would like to be part of the Guinea bio risk organization to promote the biosecurity, biosafety and the
bio threat risk reduction in Guinea.
alphaguinea@gmail.comCapacity building through training of 120
laboratory professionals in Bio risk (biosecurity
and biosafety) and bio threat risk reduction in
Guinea Conakry, 2016-2017
Alpha Mahmoud Barry
1
, Natasha Griffith
2
, Fares Khalid
3
, Lamine
Koivogui
4
, Aboubacar Savané
5
1
University of Gamma l Conakry- DG Sante plus
2
UCLA/CDC Atlanta /CRDF GLOBAL
3
University of Fez Morocco
4
National Institute of Public health/ Referral National Laboratory
5
Bio medical National Laboratory Network
Journal of Clinical Immunology and Allergy, Volume: 4
DOI: 10.21767/2471-304X-C2-006
Euro Vaccines 2018